Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo

Drug Development and Industrial Pharmacy

Volumn 37, Issue 4, 2011, Pages 475-481

  Liu, Zhidong ^a   Zhang, Xinhua ^b   Wu, Haoyun ^a   Li, Jiawei ^c   Shu, Lexin ^a   Liu, Rui ^a   Li, Lin ^a   Li, Nan ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b Inner Mongolia Institute for Food and Drug Control   (China)

^c TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Baicalin; microdialysis; ocular drug delivery system; pharmacokinetics; solid lipid nanoparticles

Indexed keywords

BAICALIN; OFLOXACIN; SEPHADEX; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIALYSIS BAG DIFFUSION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; EMULSION; EYE IRRITATION; IN VITRO STUDY; IN VIVO STUDY; MICRODIALYSIS; NONHUMAN; RABBIT; SOLID STATE; ULTRASOUND; X RAY; ZETA POTENTIAL;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CORNEA; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FLAVONOIDS; LIPIDS; NANOPARTICLES; RABBITS; SOLUBILITY; X-RAY DIFFRACTION;

EID: 79953234715     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.522193     Document Type: Article

References (23)

1. Maurice DM. (1987). Kinetics of topical applied drugs. In: Saettone MS, Bucci P, Speiser P, eds. Ophthalmic drug delivery, biopharmaceutical, technological and Clinical aspects, vol 11, Fidia Research Series, Padova: Liviana Press, 19-26.
2. Cavalli R, Rosa GM, Chetoni P, Burgalassi S, Fabrizio SM. (2002). Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm, 238(1-2):241-5. (Pubitemid 34457892)
3. Mehnert W, Mader K. (2001). Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev, 47(2-3):165-6.
4. Muller RH, Maaßen S, Weyhers H, Specht F, Lucks JS. (1996). Cytotoxicity of magnetite-loaded polylactide, polylactide/ glycolide particles and solid lipid nanoparticles. Int J Pharm, 138: 85-94. (Pubitemid 26241925)
5. Qi L, Zhou R, Wang YF, Zhu YC. (1998). Study of major flavonoids in crude Scutellariae radix by micellar electrokinetic capillary chromatography. J Capillary Electrophor, 5(5-6):181-3.
6. Cheng GQ, Feng NP, Tang QW, Li L. (2001). Studies on in vitro antibacterial action of baicalin in vitro. J Chin Hosp Pharm J, 21(6):347-8.
7. Liu JP, Zhu JB, Du ZY, Qin B. (2005). Preparation and pharmacokinetic evaluation of Tashinone ||A solid lipid nanoparticles. Drug Del Ind Pharm, 31(6):551-6. (Pubitemid 41285733)
8. Schoenwald RD, Huang HS. (1983). Corneal penetration behavior of â-blocking agents: Physical chemical factors. J Pharm Sci, 72(11):1266-72. (Pubitemid 14229733)
9. Fabrizio SM, Patrizia C, Riccardo C, Gabriela, M, Laura B. (1996). Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four â-blockers, andin vitro/in vivo toxic activity. Int J Pharm, 142:103-13.
10. Draize JH, Woodard G, Calvery HO. (1994). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther, 82:377-90.
11. Lonnroth P, Jansson PA, Smith U. (1987). A microdialysis method allowing characterization of intercellular water space in humans. Am J Physio, 253(2):228-31.
12. Duchêne D, Wouessidjewe D. (1996). Pharmaceutical and medical applications of cyclodextrins. In: Dumitriu S, ed. Polysaccharides in medical applications. New York: Marcel Dekker, 575-602.
13. Qiu F, Tang X, He ZG, Li HZ. (2004). Stability of baicalin aqueous solution by validated RP-HPLC. J Chin Pharm Sci, 13(2):134-7.
14. Wang X, Luo X, Bi KS, Hong FS, Jin ZY, Dong HR. (1990). Amodified method for assaying scutellarin in radixscutellariaein Chinese pharmacopoeia. J Shenyang Coll Pharm, 7(3):208-11.
15. Camber, O. (1985). An in vitro model for determination of drug permeability through the cornea. Acta Pharm Suec, 22(6):335-42. (Pubitemid 16184699)
16. Gokce EH, Sandri G, Bonferoni MC, Rossi, S, Ferrari F, Güneri T, Caramella C. (2008). Cyclosporine A loaded SLNS: Evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm, 364(1):76-86.
17. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. (2010). Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine, 6(2):324-33.
18. Attama AA, Reichl S, Müller-Goymann CC. (2008). Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm, 355(1-2):307-13.
19. Müller-Goymann CC. (2004). Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm, 58(2):343-56. (Pubitemid 39037240)
20. Maurice DM, Riley MV. (1970). Ocular pharmacokinetics. In: Gragmore CN, ed., Biochemistry of the eye. London: Academic Press, 6-16.
21. Wilson B, Samanta MK, Santhi K, Kumar KPS, Parmakrishnan N, Sursh B. (2008). Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur J Pharm Bio, 70(1):75-84.
22. Costa P, Lobo JMS. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13(2):123-33. (Pubitemid 32288781)
23. Gibaldi, M. (1998). Regulating angiogenesis: A new therapeuric strategy. J Clin Pharmacol, 38(10):898-903. (Pubitemid 28482114)